Introduction
Diabetic ketoacidosis (DKA) is defined as all of the following:  Blood glucose above 11 mmol/L or known history of diabetes  Blood ketones above 3mmol/L  Venous pH less than 7.3 and/or venous bicarbonate less than 15mmol/L DKA is a medical emergency and is treated by fluid therapy, electrolyte replacement and correction of blood glucose and ketones with insulin.
The WUTH diabetic ketoacidosis care pathway (intended for use in ED and general wards) is NOT entirely appropriate for critical care patients where invasive monitoring allows more patient specific fluid management. Compound sodium lactate may also be a more appropriate fluid to use instead of 0.9% sodium chloride due to the risks associated with hyperchloraemic acidosis.
Blood ketone meters for measuring at the bedside are available. Management should focus on clearing ketones alongside normalising blood glucose. Intravenous infusions of glucose 10% or 20% may be required to prevent hypoglycaemia and allow continued insulin infusion to clear blood ketones.
Management 2.1 Insulin
Consider starting an intravenous insulin infusion 1unit/ml at 0.1units/kg/hour, e.g. the starting rate in a 90kg patient would be 9ml/hour. Pre prepared insulin syringes 50units in 50ml sodium chloride 0.9% available from pharmacy should always be used.
Long acting insulin (Levemir ® or Lantus ® ) MUST BE CONTINUED in addition to intravenous insulin during DKA treatment.
Intravenous fluids
In severe DKA (pH <7.0), patients are commonly dehydrated by 10% or more (>6 litres for most adults). Initial fluid challenges to correct hypotension are followed by steady deficit replacement. Fluid therapy to be managed on a case-by-case basis by ITU registrar/consultant according to clinical judgement. Sepsis can trigger DKA, which may need concurrent vasopressor therapy.  Transfer to GKI infusion, particularly if not tolerating oral diet.
Glucose
Blood glucose must be monitored every hour, aiming for a reduction of 3mmol/L/hour.
A rapid reduction in blood glucose e.g more than 5mmol/L/hour may precipitate cerebral oedema.
When blood glucose falls below 14mmol/L, a 10% glucose infusion should be started at 125mL/hour. The infusion should be titrated to maintain blood glucose between 5 and 10mmol/L. Continue the insulin infusion until ketones are in range (<1mmol/L). If volume overload is a concern, a glucose 20% infusion may be substituted.
In cases of hypoglycaemia (blood glucose below 4mmol/L), consider giving glucose 50% bolus rather than stopping insulin. CASES OF HYPOGLYCAEMIA MUST be discussed with a doctor.
Electrolytes
In DKA there is a risk of hypoglycaemia, hypokalaemia and hyperkalaemia. Potassium should be monitored at least FOUR times daily. Aim to maintain potassium between 4 and 5mmol/L. Sodium levels should not increase by more than 0.5 to 1.0 mmol/L per hour or by more than 12mmol/L in a 24-hour period.
Arterial or venous blood gases
Should be monitored until sustained improvement in pH and blood ketones. Values of interest include bicarbonate, chloride, PCO2 and pH.
3.5 CNS observations Should be repeated 4 hourly. 
Additional Notes

